Immune reconstitution plays a crucial role on the outcome of patients given T cell-depleted HLA-haploidentical hematopoietic stem cell transplantation (hHSCT) for hematological malignancies. CD1d-restricted invariant NKT (iNKT) cells are innate-like, lipidreactive T lymphocytes controlling infections, cancer, and autoimmunity. Adult mature iNKT cells are divided in two functionally distinct CD4+ and CD4- subsets that express the NK receptor CD161 and derive from thymic CD4+CD1612 precursors. We investigated iNKT cell reconstitution dynamics in 33 pediatric patients given hHSCT for hematological malignancies, with a follow-up reaching 6 y posttransplantation, and correlated their emergence with disease relapse. iNKT cells fully reconstitute and rapidly convert into IFN-γ-expressing effectors in the 25 patients maintaining remission. CD4+ cells emerge earlier than the CD4- ones, both displaying CD1612 immature phenotypes. CD4- cells expand more slowly than CD4+ cells, though they mature with significantly faster kinetics, reaching full maturation by 18 mo post-hHSCT. Between 4 and 6 y post-hHSCT, mature CD4- iNKT cells undergo a substantial expansion burst, resulting in a CD4 +

Invariant NKT cell reconstitution in pediatric leukemia patients given HLA-haploidentical stem cell transplantation defines distinct CD4+ and CD4-subset dynamics and correlates with remission state / De Lalla, C.; Rinaldi, A.; Montagna, D.; Azzimonti, L.; Bernardo, M. E.; Sangalli, L. M.; Paganoni, A. M.; Maccario, R.; Cesare-Merlone, A. D.; Zecca, M.; Locatelli, F.; Dellabona, P.; Casorati, G.. - In: JOURNAL OF IMMUNOLOGY. - ISSN 0022-1767. - 186:7(2011), pp. 4490-4499. [10.4049/jimmunol.1003748]

Invariant NKT cell reconstitution in pediatric leukemia patients given HLA-haploidentical stem cell transplantation defines distinct CD4+ and CD4-subset dynamics and correlates with remission state

Bernardo M. E.
Data Curation
;
2011-01-01

Abstract

Immune reconstitution plays a crucial role on the outcome of patients given T cell-depleted HLA-haploidentical hematopoietic stem cell transplantation (hHSCT) for hematological malignancies. CD1d-restricted invariant NKT (iNKT) cells are innate-like, lipidreactive T lymphocytes controlling infections, cancer, and autoimmunity. Adult mature iNKT cells are divided in two functionally distinct CD4+ and CD4- subsets that express the NK receptor CD161 and derive from thymic CD4+CD1612 precursors. We investigated iNKT cell reconstitution dynamics in 33 pediatric patients given hHSCT for hematological malignancies, with a follow-up reaching 6 y posttransplantation, and correlated their emergence with disease relapse. iNKT cells fully reconstitute and rapidly convert into IFN-γ-expressing effectors in the 25 patients maintaining remission. CD4+ cells emerge earlier than the CD4- ones, both displaying CD1612 immature phenotypes. CD4- cells expand more slowly than CD4+ cells, though they mature with significantly faster kinetics, reaching full maturation by 18 mo post-hHSCT. Between 4 and 6 y post-hHSCT, mature CD4- iNKT cells undergo a substantial expansion burst, resulting in a CD4 +
2011
Acute Disease
Adolescent
Animals
CD4-Positive T-Lymphocytes
Cell Differentiation
Child
Child, Preschool
Female
HLA Antigens
Humans
Leukemia
Longitudinal Studies
Male
Mice
Natural Killer T-Cells
Remission Induction
Young Adult
Cell Proliferation
Hematopoietic Stem Cell Transplantation
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/106162
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 72
  • ???jsp.display-item.citation.isi??? 65
social impact